Literature DB >> 7298271

Drug fever due to nomifensine treatment in patients with endogenous depression.

J L Nielsen, N O Lund.   

Abstract

Nomifensine was introduced as an effective antidepressant drug with few side effects. However, among our patients we have seen 2 typical cases of drug fever due to nomifensine. 2-4 weeks after start of nomifensine treatment, 75-150 mg/day, for recurrent endogenous depressions the patients developed shiverings and fever. Nomifensine was withdrawn and both became afebrile within 1 day. A provocation test with 50 mg nomifensine p.o. again resulted in shiverings and fever within 6-8 h. 1 of the patients was allergic to other drugs and suffered from asthma. During the acute episode of illness the serum concentration of alanine aminotransferase was elevated and it normalized after stopping the treatment. A liver biopsy at that time showed liver cell necrosis, and a moderate grade of steatosis and fibrosis was also present. The results indicate that nomifensine may cause drug fever. It is possible that patients with allergy and/or liver diseases in particular may be susceptible to drug fever due to nomifensine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7298271     DOI: 10.1159/000468476

Source DB:  PubMed          Journal:  Int Pharmacopsychiatry        ISSN: 0020-8272


  1 in total

1.  Azepines and piperidines with dual norepinephrine dopamine uptake inhibition and antidepressant activity.

Authors:  Dean G Brown; Peter R Bernstein; Ye Wu; Rebecca A Urbanek; Christopher W Becker; Scott R Throner; Bruce T Dembofsky; Gary B Steelman; Lois A Lazor; Clay W Scott; Michael W Wood; Steven S Wesolowski; David A Nugiel; Stephanie Koch; Jian Yu; Donald E Pivonka; Shuang Li; Carol Thompson; Anna Zacco; Charles S Elmore; Patricia Schroeder; JianWei Liu; Christopher A Hurley; Stuart Ward; Hazel J Hunt; Karen Williams; Joseph McLaughlin; Valerie Hoesch; Simon Sydserff; Donna Maier; David Aharony
Journal:  ACS Med Chem Lett       Date:  2012-11-12       Impact factor: 4.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.